Medical Cannabis Leader IM Cannabis Sets Q1 2025 Earnings Release: Key Markets Update Comi
May 6, 2025
Rhea-AI Impact
Rhea-AI Sentiment
Rhea-AI Summary
IM Cannabis Corp. (NASDAQ: IMCC), a prominent medical cannabis company operating in Israel and Germany, has scheduled its first quarter 2025 financial results announcement for Thursday, May 15th, 2025, before market opening. The company will host a zoom conference at 9:00 AM ET on the same day to discuss the results and conduct a Q&A session with investors. Those unable to attend can access a recording on the company’s investor relations website within 24 hours after the call.
IM Cannabis Corp. (NASDAQ: IMCC), un’importante azienda di cannabis medica attiva in Israele e Germania, ha programmato la comunicazione dei risultati finanziari del primo trimestre 2025 per giovedì 15 maggio 2025, prima dell’apertura dei mercati. La società terrà una conferenza Zoom alle 9:00 AM ET dello stesso giorno per discutere i risultati e rispondere alle domande degli investitori. Chi non potrà partecipare potrà accedere alla registrazione sul sito web delle relazioni con gli investitori entro 24 ore dalla chiamata.
IM Cannabis Corp. (NASDAQ: IMCC), una destacada empresa de cannabis medicinal que opera en Israel y Alemania, ha programado el anuncio de resultados financieros del primer trimestre de 2025 para el jueves 15 de mayo de 2025, antes de la apertura del mercado. La compañía realizará una conferencia por Zoom a las 9:00 AM ET el mismo día para discutir los resultados y llevar a cabo una sesión de preguntas y respuestas con los inversores. Quienes no puedan asistir podrán acceder a la grabación en el sitio web de relaciones con inversores dentro de las 24 horas posteriores a la llamada.
IM Cannabis Corp. (NASDAQ: IMCC)는 이스라엘과 독일에서 활동하는 주요 의료용 대마초 회사로, 2025년 1분기 재무 결과 발표를 2025년 5월 15일 목요일 시장 개장 전으로 예정하고 있습니다. 회사는 같은 날 동부 표준시 오전 9시에 줌 컨퍼런스를 개최하여 결과를 논의하고 투자자들과 질의응답 시간을 가질 예정입니다. 참석하지 못하는 분들은 통화 후 24시간 이내에 회사 투자자 관계 웹사이트에서 녹화 영상을 시청할 수 있습니다.
IM Cannabis Corp. (NASDAQ: IMCC), une entreprise majeure de cannabis médical opérant en Israël et en Allemagne, a prévu l’annonce des résultats financiers du premier trimestre 2025 pour le jeudi 15 mai 2025, avant l’ouverture des marchés. La société organisera une conférence Zoom à 9h00 ET le même jour pour discuter des résultats et tenir une séance de questions-réponses avec les investisseurs. Ceux qui ne pourront pas assister pourront accéder à un enregistrement sur le site des relations investisseurs de la société dans les 24 heures suivant l’appel.
IM Cannabis Corp. (NASDAQ: IMCC), ein führendes medizinisches Cannabisunternehmen, das in Israel und Deutschland tätig ist, hat die Veröffentlichung der Finanzergebnisse für das erste Quartal 2025 für Donnerstag, den 15. Mai 2025, vor Markteröffnung, geplant. Das Unternehmen wird am selben Tag um 9:00 Uhr ET eine Zoom-Konferenz abhalten, um die Ergebnisse zu besprechen und eine Fragerunde mit Investoren durchzuführen. Wer nicht teilnehmen kann, kann innerhalb von 24 Stunden nach dem Anruf eine Aufzeichnung auf der Investor-Relations-Webseite des Unternehmens abrufen.
Positive
Negative
05/06/2025 – 07:00 AM
TORONTO and GLIL YAM, Israel, May 6, 2025 /PRNewswire/ — IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the “Company“, “IMCannabis“, or “IMC“), a leading medical cannabis company with operations in Israel and Germany, will report operational and financial results for the first quarter 2025 ended March 31, 2025, on Thursday, May 15, 2025, before the market opens.
The Company will host a zoom web conference on the same day at 9:00am ET to discuss the results, followed by a question-and-answer session for the investment community. Investors are invited to register by clicking here. All relevant information will be sent upon registration.
If you are unable to join us live, a recording of the call will be available on our website at https://investors.imcannabis.com within 24 hours after the call.
Link for the zoom call:
https://us02web.zoom.us/j/82140859987?pwd=bMnLyv9nV9C0vyIttzmLGrWmhkR5nY.1
About IM Cannabis Corp.
IMC (Nasdaq: IMCC) (CSE: IMCC) is an international cannabis company that provides premium cannabis products to medical patients in Israel and Germany, two of the largest medical cannabis markets. The Company’s focus is to achieve sustainable and profitable growth in its highest value markets, Israel and Germany. The Company leverages a transnational ecosystem powered by a unique data-driven approach and a globally sourced product supply chain. With an unwavering commitment to responsible growth and compliance with the strictest regulatory environments, the Company strives to amplify its commercial and brand power to become a global high-quality cannabis player.
The IMC ecosystem operates in Israel through its commercial relationship with Focus Medical Herbs Ltd., which imports and distributes cannabis to medical patients, leveraging years of proprietary data and patient insights. The Company also operates medical cannabis retail pharmacies, online platforms, distribution centers, and logistical hubs in Israel that enable the safe delivery and quality control of IMC products throughout the entire value chain. In Germany, the IMC ecosystem operates through Adjupharm GmbH, where it distributes cannabis to pharmacies for medical cannabis patients.
Company Contact:
Anna Taranko, Director Investor & Public Relations
IM Cannabis Corp.
+49 157 80554338
a.taranko@imcannabis.de
Oren Shuster, CEO
IM Cannabis Corp.
+972-77-3603504
info@imcannabis.com
Logo: https://mma.prnewswire.com/media/1742228/IM_Cannabis_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/im-cannabis-to-report-first-quarter-2025-financial-results-on-thursday-may-15th-at-900am-et-302447018.html
SOURCE IM Cannabis Corp.
When will IM Cannabis (IMCC) release Q1 2025 earnings?
IM Cannabis will release its Q1 2025 earnings on Thursday, May 15th, 2025, before the market opens.
What time is the IMCC Q1 2025 earnings conference call?
The earnings conference call is scheduled for Thursday, May 15th, 2025, at 9:00 AM ET via Zoom.
How can investors access IM Cannabis’ Q1 2025 earnings call?
Investors can register for the Zoom call through a registration link provided by the company. Those unable to attend can access a recording on the company’s investor website within 24 hours.
In which markets does IM Cannabis (IMCC) operate?
IM Cannabis operates in Israel and Germany as a medical cannabis company.
IMCC Rankings
IMCC Latest News
Apr 11, 2025
Mar 20, 2025
Jan 17, 2025
Nov 14, 2024
IMCC Stock Data
4.44M
1.86M
43.88%
3.91%
0.26%
Drug Manufacturers – Specialty & Generic
Healthcare
Israel
Tel Aviv
Search
RECENT PRESS RELEASES
Related Post
